Global Cosmetic Filler Injection 麻豆原创 Growth 2025-2031

Publication ID:

LPI03259687

Publication Date:

March 31, 2025

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cosmetic Filler Injection market size is predicted to grow from US$ 7236 million in 2025 to US$ 13310 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
The total size of the global beauty industry in 2022 was about US$ 427 billion, with the sales of skin care products was about US$ 190 billion, perfumes US$ 70 billion, color cosmetics US$ 80 billion, hair care products US$ 90 billion. Head beauty and personal care companies are concentrated in Europe and the United States. More than one-third of the top 100 companies are headquartered in the United States, and 22.9% of the companies are located in France.
The 鈥淐osmetic Filler Injection Industry Forecast鈥� looks at past sales and reviews total world Cosmetic Filler Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Cosmetic Filler Injection sales for 2025 through 2031. With Cosmetic Filler Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cosmetic Filler Injection industry.
This Insight Report provides a comprehensive analysis of the global Cosmetic Filler Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cosmetic Filler Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cosmetic Filler Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cosmetic Filler Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cosmetic Filler Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Cosmetic Filler Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wrinkle Relaxers
Dermal Fillers
Segmentation by Application:
Lip Augmentation
Facial Line Correction
Acne Scar Treatment
Lipoatrophy Treatment
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Luminera
ALLERGAN
Anika Therapeutics,Inc
Medytox
Merz Pharma
Nestl茅 Skin Health
Galderma Laboratories,L.P
Sinclair Pharma
Suneva Medical
Teoxane
Bausch Health
Sanofi
Shanghai Fosun Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cosmetic Filler Injection market?
What factors are driving Cosmetic Filler Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cosmetic Filler Injection market opportunities vary by end market size?
How does Cosmetic Filler Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Cosmetic Filler Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cosmetic Filler Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cosmetic Filler Injection by Country/Region, 2020, 2024 & 2031
2.2 Cosmetic Filler Injection Segment by Type
2.2.1 Wrinkle Relaxers
2.2.2 Dermal Fillers
2.3 Cosmetic Filler Injection Sales by Type
2.3.1 Global Cosmetic Filler Injection Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Cosmetic Filler Injection Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Cosmetic Filler Injection Sale Price by Type (2020-2025)
2.4 Cosmetic Filler Injection Segment by Application
2.4.1 Lip Augmentation
2.4.2 Facial Line Correction
2.4.3 Acne Scar Treatment
2.4.4 Lipoatrophy Treatment
2.4.5 Others
2.5 Cosmetic Filler Injection Sales by Application
2.5.1 Global Cosmetic Filler Injection Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Cosmetic Filler Injection Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Cosmetic Filler Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Cosmetic Filler Injection Breakdown Data by Company
3.1.1 Global Cosmetic Filler Injection Annual Sales by Company (2020-2025)
3.1.2 Global Cosmetic Filler Injection Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Cosmetic Filler Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Cosmetic Filler Injection Revenue by Company (2020-2025)
3.2.2 Global Cosmetic Filler Injection Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Cosmetic Filler Injection Sale Price by Company
3.4 Key Manufacturers Cosmetic Filler Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cosmetic Filler Injection Product Location Distribution
3.4.2 Players Cosmetic Filler Injection Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Cosmetic Filler Injection by Geographic Region
4.1 World Historic Cosmetic Filler Injection 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Cosmetic Filler Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cosmetic Filler Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cosmetic Filler Injection 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Cosmetic Filler Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cosmetic Filler Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cosmetic Filler Injection Sales Growth
4.4 APAC Cosmetic Filler Injection Sales Growth
4.5 Europe Cosmetic Filler Injection Sales Growth
4.6 Middle East & Africa Cosmetic Filler Injection Sales Growth
5 Americas
5.1 Americas Cosmetic Filler Injection Sales by Country
5.1.1 Americas Cosmetic Filler Injection Sales by Country (2020-2025)
5.1.2 Americas Cosmetic Filler Injection Revenue by Country (2020-2025)
5.2 Americas Cosmetic Filler Injection Sales by Type (2020-2025)
5.3 Americas Cosmetic Filler Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cosmetic Filler Injection Sales by Region
6.1.1 APAC Cosmetic Filler Injection Sales by Region (2020-2025)
6.1.2 APAC Cosmetic Filler Injection Revenue by Region (2020-2025)
6.2 APAC Cosmetic Filler Injection Sales by Type (2020-2025)
6.3 APAC Cosmetic Filler Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cosmetic Filler Injection by Country
7.1.1 Europe Cosmetic Filler Injection Sales by Country (2020-2025)
7.1.2 Europe Cosmetic Filler Injection Revenue by Country (2020-2025)
7.2 Europe Cosmetic Filler Injection Sales by Type (2020-2025)
7.3 Europe Cosmetic Filler Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cosmetic Filler Injection by Country
8.1.1 Middle East & Africa Cosmetic Filler Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cosmetic Filler Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Cosmetic Filler Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Cosmetic Filler Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cosmetic Filler Injection
10.3 Manufacturing Process Analysis of Cosmetic Filler Injection
10.4 Industry Chain Structure of Cosmetic Filler Injection
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cosmetic Filler Injection Distributors
11.3 Cosmetic Filler Injection Customer
12 World Forecast Review for Cosmetic Filler Injection by Geographic Region
12.1 Global Cosmetic Filler Injection 麻豆原创 Size Forecast by Region
12.1.1 Global Cosmetic Filler Injection Forecast by Region (2026-2031)
12.1.2 Global Cosmetic Filler Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cosmetic Filler Injection Forecast by Type (2026-2031)
12.7 Global Cosmetic Filler Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Luminera
13.1.1 Luminera Company Information
13.1.2 Luminera Cosmetic Filler Injection Product Portfolios and Specifications
13.1.3 Luminera Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Luminera Main Business Overview
13.1.5 Luminera Latest Developments
13.2 ALLERGAN
13.2.1 ALLERGAN Company Information
13.2.2 ALLERGAN Cosmetic Filler Injection Product Portfolios and Specifications
13.2.3 ALLERGAN Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 ALLERGAN Main Business Overview
13.2.5 ALLERGAN Latest Developments
13.3 Anika Therapeutics,Inc
13.3.1 Anika Therapeutics,Inc Company Information
13.3.2 Anika Therapeutics,Inc Cosmetic Filler Injection Product Portfolios and Specifications
13.3.3 Anika Therapeutics,Inc Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Anika Therapeutics,Inc Main Business Overview
13.3.5 Anika Therapeutics,Inc Latest Developments
13.4 Medytox
13.4.1 Medytox Company Information
13.4.2 Medytox Cosmetic Filler Injection Product Portfolios and Specifications
13.4.3 Medytox Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Medytox Main Business Overview
13.4.5 Medytox Latest Developments
13.5 Merz Pharma
13.5.1 Merz Pharma Company Information
13.5.2 Merz Pharma Cosmetic Filler Injection Product Portfolios and Specifications
13.5.3 Merz Pharma Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merz Pharma Main Business Overview
13.5.5 Merz Pharma Latest Developments
13.6 Nestl茅 Skin Health
13.6.1 Nestl茅 Skin Health Company Information
13.6.2 Nestl茅 Skin Health Cosmetic Filler Injection Product Portfolios and Specifications
13.6.3 Nestl茅 Skin Health Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Nestl茅 Skin Health Main Business Overview
13.6.5 Nestl茅 Skin Health Latest Developments
13.7 Galderma Laboratories,L.P
13.7.1 Galderma Laboratories,L.P Company Information
13.7.2 Galderma Laboratories,L.P Cosmetic Filler Injection Product Portfolios and Specifications
13.7.3 Galderma Laboratories,L.P Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Galderma Laboratories,L.P Main Business Overview
13.7.5 Galderma Laboratories,L.P Latest Developments
13.8 Sinclair Pharma
13.8.1 Sinclair Pharma Company Information
13.8.2 Sinclair Pharma Cosmetic Filler Injection Product Portfolios and Specifications
13.8.3 Sinclair Pharma Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sinclair Pharma Main Business Overview
13.8.5 Sinclair Pharma Latest Developments
13.9 Suneva Medical
13.9.1 Suneva Medical Company Information
13.9.2 Suneva Medical Cosmetic Filler Injection Product Portfolios and Specifications
13.9.3 Suneva Medical Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Suneva Medical Main Business Overview
13.9.5 Suneva Medical Latest Developments
13.10 Teoxane
13.10.1 Teoxane Company Information
13.10.2 Teoxane Cosmetic Filler Injection Product Portfolios and Specifications
13.10.3 Teoxane Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Teoxane Main Business Overview
13.10.5 Teoxane Latest Developments
13.11 Bausch Health
13.11.1 Bausch Health Company Information
13.11.2 Bausch Health Cosmetic Filler Injection Product Portfolios and Specifications
13.11.3 Bausch Health Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bausch Health Main Business Overview
13.11.5 Bausch Health Latest Developments
13.12 Sanofi
13.12.1 Sanofi Company Information
13.12.2 Sanofi Cosmetic Filler Injection Product Portfolios and Specifications
13.12.3 Sanofi Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanofi Main Business Overview
13.12.5 Sanofi Latest Developments
13.13 Shanghai Fosun Pharmaceutical
13.13.1 Shanghai Fosun Pharmaceutical Company Information
13.13.2 Shanghai Fosun Pharmaceutical Cosmetic Filler Injection Product Portfolios and Specifications
13.13.3 Shanghai Fosun Pharmaceutical Cosmetic Filler Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shanghai Fosun Pharmaceutical Main Business Overview
13.13.5 Shanghai Fosun Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.